Therapy for neovascular age-related macular degeneration: updated review

Abstract

Age-related macular degeneration (AMD) constitutes a prevalent, chronic, and progressive retinal degenerative disease of the macula that affects elderly people and cause central vision impairment Neovascular (“wet”) form of age-related macular degeneration (nAMD) is the leading cause of irreversible visual impairment in people over the age of 60 in economically advanced countries. Until recent time, the diagnosis of nAMD was actually a verdict for the patient in terms of visual prognosis - it was clear to both doctors and patients that a decrease in central vision was inevitable, the only question was the timing of maintaining functionally useful vision of the affected eye, as well as the timing of damage to the fellow eye and disability of the patient.